NCT01066754View on ClinicalTrials.gov

Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2002

Study Completion Date

May 31, 2002

Conditions
Healthy
Interventions
DRUG

Fexofenadine

Fexofenadine Hydrochloride 180 mg Tablets

Trial Locations (1)

G1V 2K8

Anapharm Inc.,, Sainte-Foy Quebec

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY